Nyxoah SA Total Assets 2021-2025 | NYXH
Nyxoah SA total assets from 2021 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Nyxoah SA Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $171 |
| 2023 | $134 |
| 2022 | $154 |
| 2021 | $202 |
| 2020 | $130 |
| Nyxoah SA Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $143 |
| 2024-12-31 | $171 |
| 2024-09-30 | $157 |
| 2024-06-30 | $160 |
| 2024-03-31 | $123 |
| 2023-12-31 | $134 |
| 2023-09-30 | $147 |
| 2023-06-30 | $155 |
| 2023-03-31 | $162 |
| 2022-12-31 | $154 |
| 2022-09-30 | $165 |
| 2022-06-30 | $178 |
| 2022-03-31 | $186 |
| 2021-12-31 | $0 |
| 2021-03-31 | $133 |
| 2020-12-31 | $130 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.264B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.731B | 53.50 |
| Hims & Hers Health (HIMS) | United States | $11.944B | 124.09 |
| Tempus AI (TEM) | United States | $11.403B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.673B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.222B | 65.97 |
| Privia Health (PRVA) | United States | $2.843B | 194.33 |
| Enovis (ENOV) | United States | $1.910B | 10.65 |
| Clover Health Investments (CLOV) | United States | $1.634B | 0.00 |
| Schrodinger (SDGR) | United States | $1.578B | 0.00 |
| Phreesia (PHR) | United States | $1.484B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.47 |
| Azenta (AZTA) | United States | $1.269B | 58.98 |
| 10x Genomics (TXG) | United States | $1.058B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.626B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.615B | 0.00 |
| Talkspace (TALK) | United States | $0.494B | 147.50 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.450B | 0.00 |
| Standard BioTools (LAB) | United States | $0.391B | 0.00 |
| TruBridge (TBRG) | United States | $0.361B | 801.00 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.193B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.134B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.32 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |